che-chandler.de
COMMERCIALIZING THE STEM CELL
Alle Preise inkl. MwSt. | Versandkostenfrei
Nicht verfügbar
Zum Merkzettel
Beschreibung:
Dr Olivia Harvey is currently a Visiting Fellow with the Biopolitics of Science Research Network at the University of Sydney, Australia. She was previously a Faculty of Arts and Social Sciences Postdoctoral Research Fellow and Research Fellow in the School of History and Philosophy at the University of New South Wales, and an Economic and Social Research Council Postdoctoral Research Fellow and Research Fellow with the Global Biopolitics Research Group (formerly of the University of East Anglia), Centre for Biomedicine and Society (now at Brunel University), King's College, London.
Introduction: Stem cell science, biotechnology and the problem of commercialization; Stem cell treatments in a global marketplace; The role of innovation systems in the commercialization of biotechnology; Low-risk, low-value: Adult stem cells; High-risk, high-value: Embryonic stem cells; Low-risk, low-value: iPS cells; What does the future hold?
Commercializing the stem cell sciences offers a comparative analysis of the commercial models adopted in the global stem cell industries, focusing on case-studies of publicly available information about different companies around the world working on adapting stem cell technologies to market.